Status:
COMPLETED
sFlt-1:PlGF Ratio in Diagnosing Superimposed Preeclampsia
Lead Sponsor:
University of Tennessee
Conditions:
Preeclampsia
Eligibility:
FEMALE
14-45 years
Brief Summary
Preeclampsia: associated with poor placentation, incomplete uteroplacental spiral arteries remodeling. Result: ischemia, re-perfusion injury, oxidative stress. A low-grade systemic inflammatory respo...
Detailed Description
Subjects with a diagnosis of chronic hypertension made prenatally or in the first 20 weeks of pregnancy (+/- medical therapy). The clinical diagnosis of preeclampsia will follow the current criteria o...
Eligibility Criteria
Inclusion
- Gestational age at enrollment: 20 0/7 weeks to 38 6/7 weeks gestation Pregnant women aged 14 to 45 years
- Presenting for admission for suspected superimposed preeclampsia
- Diagnosis of chronic hypertension made prenatally or in the first 20 weeks of pregnancy (+/- medical therapy)
- The clinical diagnosis of preeclampsia will follow the current criteria outlined by ACOG 10.
Exclusion
- Age 45 years;
- Gestational age 19 6/7 weeks or less or 39 weeks or more ;
- Multiple gestations.
Key Trial Info
Start Date :
February 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03441711
Start Date
February 1 2016
End Date
June 30 2020
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional One Health Center for High Risk Pregnancies
Memphis, Tennessee, United States, 38120